Ability 0 7 0 7 O
to 8 10 8 10 O
swallow 11 18 11 18 O
and 19 22 19 22 O
retain 23 29 23 29 O
oral 30 34 30 34 B-treatment
medication 35 45 35 45 I-treatment

Absolute 0 8 46 54 B-clinical_variable
neutrophil 9 19 55 65 I-clinical_variable
count 20 25 66 71 I-clinical_variable
( 26 27 72 73 I-clinical_variable
ANC 27 30 73 76 I-clinical_variable
) 30 31 76 77 I-clinical_variable
≥1.25 32 37 78 83 O
x 38 39 84 85 I-lower_bound
109 40 43 86 89 I-lower_bound
/ 43 44 89 90 I-lower_bound
L 44 45 90 91 I-lower_bound

Active 0 6 92 98 O
brain 7 12 99 104 B-cancer
metastases 13 23 105 115 I-cancer
or 24 26 116 118 O
leptomeningeal 27 41 119 133 B-cancer
disease 42 49 134 141 I-cancer

Archived 0 8 142 150 B-cancer
tumor 9 14 151 156 I-cancer
tissue 15 21 157 163 I-cancer
from 22 26 164 168 O
a 27 28 169 170 O
primary 29 36 171 178 B-treatment
biopsy 37 43 179 185 I-treatment
or 44 46 186 188 O
metastatic 47 57 189 199 B-cancer
lesion 58 64 200 206 O
for 65 68 207 210 O
centralized 69 80 211 222 O
determination 81 94 223 236 O
of 95 97 237 239 O
AR 98 100 240 242 O
expression 101 111 243 253 O
is 112 114 254 256 O
mandatory 115 124 257 266 O

Chronic 0 7 267 274 O
stable 8 14 275 281 O
atrial 15 21 282 288 B-chronic_disease
fibrillation 22 34 289 301 I-chronic_disease
on 35 37 302 304 O
stable 38 44 305 311 O
anticoagulant 45 58 312 325 B-treatment
therapy 59 66 326 333 I-treatment

Creatinine 0 10 334 344 B-clinical_variable
≤1.5 11 15 345 349 O
x 16 17 350 351 I-lower_bound
ULN 18 21 352 355 I-lower_bound
or 22 24 356 358 O
creatinine 25 35 359 369 B-clinical_variable
clearance 36 45 370 379 I-clinical_variable
≥40 46 49 380 383 O
mL 50 52 384 386 I-lower_bound
/ 52 53 386 387 I-lower_bound
min 53 56 387 390 I-lower_bound
as 57 59 391 393 O
calculated 60 70 394 404 O
by 71 73 405 407 O
the 74 77 408 411 O
Cockcroft 78 87 412 421 B-clinical_variable
- 87 88 421 422 I-clinical_variable
Gault 88 93 422 427 I-clinical_variable
method 94 100 428 434 I-clinical_variable

Eastern 0 7 435 442 B-clinical_variable
Cooperative 8 19 443 454 I-clinical_variable
Oncology 20 28 455 463 I-clinical_variable
Group 29 34 464 469 I-clinical_variable
( 35 36 470 471 I-clinical_variable
ECOG 36 40 471 475 I-clinical_variable
) 40 41 475 476 I-clinical_variable
performance 42 53 477 488 I-clinical_variable
status 54 60 489 495 I-clinical_variable
score 61 66 496 501 I-clinical_variable
of 67 69 502 504 O
0 70 71 505 506 B-lower_bound
, 71 72 506 507 O
1 73 74 508 509 O
, 74 75 509 510 O
or 76 78 511 513 O
2 79 80 514 515 B-upper_bound

Female 0 6 516 522 B-gender

Female 0 6 523 529 B-gender
patients 7 15 530 538 I-gender
who 16 19 539 542 O
are 20 23 543 546 O
both 24 28 547 551 O
lactating 29 38 552 561 O
and 39 42 562 565 O
breastfeeding 43 56 566 579 O
or 57 59 580 582 O
have 60 64 583 587 O
a 65 66 588 589 O
positive 67 75 590 598 B-pregnancy
serum 76 81 599 604 I-pregnancy
pregnancy 82 91 605 614 I-pregnancy
test 92 96 615 619 O
during 97 103 620 626 O
the 104 107 627 630 O
screening 108 117 631 640 O
period 118 124 641 647 O

Female 0 6 648 654 B-gender
patients 7 15 655 663 I-gender
who 16 19 664 667 O
are 20 23 668 671 O
not 24 27 672 675 O
of 28 30 676 678 O
child 31 36 679 684 O
- 36 37 684 685 O
bearing 37 44 685 692 O
potential 45 54 693 702 O
and 55 58 703 706 O
female 59 65 707 713 B-gender
patients 66 74 714 722 I-gender
of 75 77 723 725 O
child 78 83 726 731 O
- 83 84 731 732 O
bearing 84 91 732 739 O
potential 92 101 740 749 O
who 102 105 750 753 O
agree 106 111 754 759 B-contraception_consent
to 112 114 760 762 I-contraception_consent
use 115 118 763 766 I-contraception_consent
adequate 119 127 767 775 I-contraception_consent
contraceptive 128 141 776 789 I-contraception_consent
measures 142 150 790 798 I-contraception_consent
or 151 153 799 801 O
abstain 154 161 802 809 O
from 162 166 810 814 O
heterosexual 167 179 815 827 O
intercourse 180 191 828 839 O
during 192 198 840 846 O
the 199 202 847 850 O
entire 203 209 851 857 O
study 210 215 858 863 O
treatment 216 225 864 873 B-treatment
period 226 232 874 880 O
and 233 236 881 884 O
for 237 240 885 888 O
4 241 242 889 890 B-upper_bound
months 243 249 891 897 I-upper_bound
after 250 255 898 903 I-upper_bound
the 256 259 904 907 O
last 260 264 908 912 O
dose 265 269 913 917 O
of 270 272 918 920 O
study 273 278 921 926 B-treatment
drug 279 283 927 931 I-treatment
, 283 284 931 932 O
who 285 288 933 936 O
are 289 292 937 940 O
not 293 296 941 944 O
breastfeeding 297 310 945 958 O
, 310 311 958 959 O
and 312 315 960 963 O
who 316 319 964 967 O
have 320 324 968 972 O
had 325 328 973 976 O
a 329 330 977 978 O
negative 331 339 979 987 B-treatment
serum 340 345 988 993 I-treatment
/ 345 346 993 994 I-treatment
urine 346 351 994 999 I-treatment
pregnancy 352 361 1000 1009 I-treatment
test 362 366 1010 1014 I-treatment
≤7 367 369 1015 1017 O
days 370 374 1018 1022 I-upper_bound
prior 375 380 1023 1028 I-upper_bound
to 381 383 1029 1031 O
dosing 384 390 1032 1038 O

For 0 3 1039 1042 O
investigational 4 19 1043 1058 B-treatment
drugs 20 25 1059 1064 I-treatment
for 26 29 1065 1068 O
which 30 35 1069 1074 O
5 36 37 1075 1076 O
half 38 42 1077 1081 O
- 42 43 1081 1082 O
lives 43 48 1082 1087 O
is 49 51 1088 1090 O
less 52 56 1091 1095 O
than 57 61 1096 1100 O
21 62 64 1101 1103 B-upper_bound
days 65 69 1104 1108 I-upper_bound
, 69 70 1108 1109 O
a 71 72 1110 1111 O
minimum 73 80 1112 1119 O
of 81 83 1120 1122 O
10 84 86 1123 1125 B-lower_bound
days 87 91 1126 1130 I-lower_bound
between 92 99 1131 1138 O
termination 100 111 1139 1150 O
of 112 114 1151 1153 O
the 115 118 1154 1157 O
investigational 119 134 1158 1173 O
drug 135 139 1174 1178 O
and 140 143 1179 1182 O
administration 144 158 1183 1197 O
of 159 161 1198 1200 O
orteronel 162 171 1201 1210 O
is 172 174 1211 1213 O
required 175 183 1214 1222 O

HER2 0 4 1223 1227 B-cancer
+ 4 5 1227 1228 O
patients 6 14 1229 1237 O
in 15 17 1238 1240 O
this 18 22 1241 1245 O
group 23 28 1246 1251 O
must 29 33 1252 1256 O
have 34 38 1257 1261 O
received 39 47 1262 1270 O
a 48 49 1271 1272 O
minimum 50 57 1273 1280 O
of 58 60 1281 1283 O
2 61 62 1284 1285 O
lines 63 68 1286 1291 O
of 69 71 1292 1294 O
HER2 72 76 1295 1299 O
- 76 77 1299 1300 O
directed 77 85 1300 1308 O
therapy 86 93 1309 1316 O
in 94 96 1317 1319 O
the 97 100 1320 1323 O
advanced 101 109 1324 1332 O
setting 110 117 1333 1340 O

Hemoglobin 0 10 1341 1351 B-clinical_variable
≥9 11 13 1352 1354 O
g 14 15 1355 1356 I-lower_bound
/ 15 16 1356 1357 I-lower_bound
dL 16 18 1357 1359 I-lower_bound

History 0 7 1360 1367 O
of 8 10 1368 1370 O
myocardial 11 21 1371 1381 B-chronic_disease
infarction 22 32 1382 1392 I-chronic_disease
, 32 33 1392 1393 O
unstable 34 42 1394 1402 O
symptomatic 43 54 1403 1414 O
ischemic 55 63 1415 1423 B-chronic_disease
heart 64 69 1424 1429 I-chronic_disease
disease 70 77 1430 1437 I-chronic_disease
, 77 78 1437 1438 O
ongoing 79 86 1439 1446 O
arrhythmias 87 98 1447 1458 B-clinical_variable
> 99 100 1459 1460 O
Grade 101 106 1461 1466 B-lower_bound
2 107 108 1467 1468 I-lower_bound
( 109 110 1469 1470 O
National 110 118 1470 1478 O
Cancer 119 125 1479 1485 O
Institute 126 135 1486 1495 O
[ 136 137 1496 1497 O
NCI 137 140 1497 1500 O
] 140 141 1500 1501 O
Common 142 148 1502 1508 O
Terminology 149 160 1509 1520 O
Criteria 161 169 1521 1529 O
for 170 173 1530 1533 O
Adverse 174 181 1534 1541 O
Events 182 188 1542 1548 O
[ 189 190 1549 1550 O
CTCAE 190 195 1550 1555 O
] 195 196 1555 1556 O
, 196 197 1556 1557 O
Version 198 205 1558 1565 O
4.0 206 209 1566 1569 O
) 209 210 1569 1570 O
, 210 211 1570 1571 O
thromboembolic 212 226 1572 1586 B-chronic_disease
events 227 233 1587 1593 I-chronic_disease
( 234 235 1594 1595 O
eg 235 237 1595 1597 O
, 237 238 1597 1598 O
deep 239 243 1599 1603 B-chronic_disease
vein 244 248 1604 1608 I-chronic_disease
thrombosis 249 259 1609 1619 I-chronic_disease
, 259 260 1619 1620 O
pulmonary 261 270 1621 1630 B-chronic_disease
embolism 271 279 1631 1639 I-chronic_disease
, 279 280 1639 1640 O
or 281 283 1641 1643 O
symptomatic 284 295 1644 1655 O
cerebrovascular 296 311 1656 1671 B-chronic_disease
events 312 318 1672 1678 I-chronic_disease
) 318 319 1678 1679 O
, 319 320 1679 1680 O
or 321 323 1681 1683 O
any 324 327 1684 1687 O
other 328 333 1688 1693 O
cardiac 334 341 1694 1701 B-chronic_disease
condition 342 351 1702 1711 I-chronic_disease
( 352 353 1712 1713 O
eg 353 355 1713 1715 O
, 355 356 1715 1716 O
pericardial 357 368 1717 1728 B-chronic_disease
effusion 369 377 1729 1737 I-chronic_disease
restrictive 378 389 1738 1749 I-chronic_disease
cardiomyopathy 390 404 1750 1764 I-chronic_disease
) 404 405 1764 1765 O
within 406 412 1766 1772 O
6 413 414 1773 1774 B-upper_bound
months 415 421 1775 1781 I-upper_bound
prior 422 427 1782 1787 I-upper_bound
to 428 430 1788 1790 O
first 431 436 1791 1796 O
dose 437 441 1797 1801 O
of 442 444 1802 1804 O
study 445 450 1805 1810 B-treatment
drug 451 455 1811 1815 I-treatment

Inadequately 0 12 1816 1828 O
controlled 13 23 1829 1839 O
hypertension 24 36 1840 1852 B-chronic_disease
( 37 38 1853 1854 O
ie 38 40 1854 1856 O
, 40 41 1856 1857 O
systolic 42 50 1858 1866 B-clinical_variable
blood 51 56 1867 1872 I-clinical_variable
pressure 57 65 1873 1881 I-clinical_variable
[ 66 67 1882 1883 I-clinical_variable
SBP 67 70 1883 1886 I-clinical_variable
] 70 71 1886 1887 I-clinical_variable
> 72 73 1888 1889 O
160 73 76 1889 1892 B-upper_bound
mmHg 77 81 1893 1897 I-upper_bound
or 82 84 1898 1900 O
diastolic 85 94 1901 1910 B-clinical_variable
BP 95 97 1911 1913 I-clinical_variable
[ 98 99 1914 1915 I-clinical_variable
DBP 99 102 1915 1918 I-clinical_variable
] 102 103 1918 1919 I-clinical_variable
> 104 105 1920 1921 O
90 105 107 1921 1923 B-lower_bound
mmHg 108 112 1924 1928 I-lower_bound
) 112 113 1928 1929 O
at 114 116 1930 1932 O
2 117 118 1933 1934 O
separate 119 127 1935 1943 O
measurements 128 140 1944 1956 O
no 141 143 1957 1959 O
more 144 148 1960 1964 O
than 149 153 1965 1969 O
60 154 156 1970 1972 B-upper_bound
minutes 157 164 1973 1980 I-upper_bound
apart 165 170 1981 1986 O
during 171 177 1987 1993 O
the 178 181 1994 1997 O
Screening 182 191 1998 2007 O
visit 192 197 2008 2013 O

Known 0 5 2014 2019 O
diagnosis 6 15 2020 2029 O
of 16 18 2030 2032 O
human 19 24 2033 2038 B-chronic_disease
immunodeficiency 25 41 2039 2055 I-chronic_disease
virus 42 47 2056 2061 I-chronic_disease
, 47 48 2061 2062 O
active 49 55 2063 2069 O
chronic 56 63 2070 2077 B-chronic_disease
hepatitis 64 73 2078 2087 I-chronic_disease
B 74 75 2088 2089 I-chronic_disease
, 75 76 2089 2090 I-chronic_disease
or 77 79 2091 2093 I-chronic_disease
C 80 81 2094 2095 I-chronic_disease
, 81 82 2095 2096 O
life 83 87 2097 2101 O
- 87 88 2101 2102 O
threatening 88 99 2102 2113 O
illness 100 107 2114 2121 O
unrelated 108 117 2122 2131 O
to 118 120 2132 2134 O
cancer 121 127 2135 2141 B-cancer
, 127 128 2141 2142 O
or 129 131 2143 2145 O
any 132 135 2146 2149 O
serious 136 143 2150 2157 O
medical 144 151 2158 2165 O
or 152 154 2166 2168 O
psychiatric 155 166 2169 2180 B-chronic_disease
illness 167 174 2181 2188 I-chronic_disease
that 175 179 2189 2193 O
could 180 185 2194 2199 O
, 185 186 2199 2200 O
in 187 189 2201 2203 O
the 190 193 2204 2207 O
investigator 194 206 2208 2220 O
's 206 208 2220 2222 O
opinion 209 216 2223 2230 O
, 216 217 2230 2231 O
potentially 218 229 2232 2243 O
interfere 230 239 2244 2253 O
with 240 244 2254 2258 O
participation 245 258 2259 2272 O
in 259 261 2273 2275 O
this 262 266 2276 2280 O
study 267 272 2281 2286 O

Known 0 5 2287 2292 O
hypersensitivity 6 22 2293 2309 O
to 23 25 2310 2312 O
orteronel 26 35 2313 2322 B-allergy_name
or 36 38 2323 2325 O
to 39 41 2326 2328 O
orteronel 42 51 2329 2338 O
excipients 52 62 2339 2349 O
, 62 63 2349 2350 O
which 64 69 2351 2356 O
are 70 73 2357 2360 O
listed 74 80 2361 2367 O
by 81 83 2368 2370 O
formulation 84 95 2371 2382 O
in 96 98 2383 2385 O
the 99 102 2386 2389 O
Investigator 103 115 2390 2402 O
Brochure 116 124 2403 2411 O

LHRH 0 4 2412 2416 O
agonists 5 13 2417 2425 O
maybe 14 19 2426 2431 O
used 20 24 2432 2436 O
to 25 27 2437 2439 O
render 28 34 2440 2446 O
ovarian 35 42 2447 2454 B-treatment
suppression 43 54 2455 2466 I-treatment
with 55 59 2467 2471 O
post 60 64 2472 2476 O
- 64 65 2476 2477 O
menopausal 65 75 2477 2487 O
ranges 76 82 2488 2494 O
of 83 85 2495 2497 O
estradiol 86 95 2498 2507 B-treatment
or 96 98 2508 2510 O
FSH 99 102 2511 2514 B-treatment
per 103 106 2515 2518 O
institutional 107 120 2519 2532 O
guidelines 121 131 2533 2543 O

Life 0 4 2544 2548 B-clinical_variable
expectancy 5 15 2549 2559 I-clinical_variable
of 16 18 2560 2562 O
≥3 19 21 2563 2565 O
months 22 28 2566 2572 I-lower_bound

Major 0 5 2573 2578 B-treatment
surgical 6 14 2579 2587 I-treatment
procedures 15 25 2588 2598 I-treatment
≤28 26 29 2599 2602 O
days 30 34 2603 2607 I-upper_bound
of 35 37 2608 2610 O
beginning 38 47 2611 2620 O
study 48 53 2621 2626 O
treatment 54 63 2627 2636 B-treatment
or 64 66 2637 2639 O
minor 67 72 2640 2645 B-treatment
surgical 73 81 2646 2654 I-treatment
procedures 82 92 2655 2665 I-treatment
≤7 93 95 2666 2668 O
days 96 100 2669 2673 I-upper_bound

Male 0 4 2674 2678 B-gender
patients 5 13 2679 2687 I-gender
( 14 15 2688 2689 O
even 15 19 2689 2693 O
those 20 25 2694 2699 O
post 26 30 2700 2704 O
vasectomy 31 40 2705 2714 B-contraception_consent
) 40 41 2714 2715 O
who 42 45 2716 2719 O
are 46 49 2720 2723 O
willing 50 57 2724 2731 B-contraception_consent
to 58 60 2732 2734 I-contraception_consent
use 61 64 2735 2738 I-contraception_consent
adequate 65 73 2739 2747 I-contraception_consent
contraceptive 74 87 2748 2761 I-contraception_consent
measures 88 96 2762 2770 I-contraception_consent
or 97 99 2771 2773 O
abstain 100 107 2774 2781 O
from 108 112 2782 2786 O
heterosexual 113 125 2787 2799 O
intercourse 126 137 2800 2811 O
during 138 144 2812 2818 O
the 145 148 2819 2822 O
entire 149 155 2823 2829 O
study 156 161 2830 2835 O
treatment 162 171 2836 2845 B-treatment
period 172 178 2846 2852 O
and 179 182 2853 2856 O
for 183 186 2857 2860 O
4 187 188 2861 2862 B-upper_bound
months 189 195 2863 2869 I-upper_bound
after 196 201 2870 2875 I-upper_bound
the 202 205 2876 2879 O
last 206 210 2880 2884 O
dose 211 215 2885 2889 O
of 216 218 2890 2892 O
study 219 224 2893 2898 O
drug 225 229 2899 2903 O

New 0 3 2904 2907 B-clinical_variable
York 4 8 2908 2912 I-clinical_variable
Heart 9 14 2913 2918 I-clinical_variable
Association 15 26 2919 2930 I-clinical_variable
( 27 28 2931 2932 I-clinical_variable
NYHA 28 32 2932 2936 I-clinical_variable
) 32 33 2936 2937 I-clinical_variable
Class 34 39 2938 2943 B-lower_bound
III 40 43 2944 2947 I-lower_bound
or 44 46 2948 2950 O
IV 47 49 2951 2953 B-upper_bound
heart 50 55 2954 2959 B-chronic_disease
failure 56 63 2960 2967 I-chronic_disease

No 0 2 2968 2970 O
waiting 3 10 2971 2978 O
is 11 13 2979 2981 O
required 14 22 2982 2990 O
following 23 32 2991 3000 O
port 33 37 3001 3005 B-treatment
- 37 38 3005 3006 I-treatment
a 38 39 3006 3007 I-treatment
- 39 40 3007 3008 I-treatment
cath 40 44 3008 3012 I-treatment
placement 45 54 3013 3022 O

Patient 0 7 3023 3030 O
has 8 11 3031 3034 O
recovered 12 21 3035 3044 O
( 22 23 3045 3046 O
to 23 25 3046 3048 O
Grade 26 31 3049 3054 B-clinical_variable
≤1 32 34 3055 3057 O
) 34 35 3057 3058 O
from 36 40 3059 3063 O
all 41 44 3064 3067 O
clinically 45 55 3068 3078 O
significant 56 67 3079 3090 O
toxicities 68 78 3091 3101 O
related 79 86 3102 3109 O
to 87 89 3110 3112 O
prior 90 95 3113 3118 O
antineoplastic 96 110 3119 3133 B-treatment
therapies 111 120 3134 3143 I-treatment

Patients 0 8 3144 3152 O
must 9 13 3153 3157 O
be 14 16 3158 3160 O
off 17 20 3161 3164 O
steroids 21 29 3165 3173 B-treatment
, 29 30 3173 3174 O
but 31 34 3175 3178 O
anti 35 39 3179 3183 B-treatment
- 39 40 3183 3184 I-treatment
convulsants 40 51 3184 3195 I-treatment
are 52 55 3196 3199 O
allowed 56 63 3200 3207 O

Patients 0 8 3208 3216 O
must 9 13 3217 3221 O
have 14 18 3222 3226 O
MBC 19 22 3227 3230 O
that 23 27 3231 3235 O
is 28 30 3236 3238 O
measurable 31 41 3239 3249 O
or 42 44 3250 3252 O
evaluable 45 54 3253 3262 O
as 55 57 3263 3265 O
defined 58 65 3266 3273 O
by 66 68 3274 3276 O
Response 69 77 3277 3285 O
Evaluation 78 88 3286 3296 O
Criteria 89 97 3297 3305 O
in 98 100 3306 3308 O
Solid 101 106 3309 3314 B-cancer
Tumors 107 113 3315 3321 I-cancer
( 114 115 3322 3323 O
RECIST 115 121 3323 3329 O
) 121 122 3329 3330 O
v1.1 123 127 3331 3335 O
criteria 128 136 3336 3344 O

Patients 0 8 3345 3353 O
receiving 9 18 3354 3363 O
chronic 19 26 3364 3371 O
bisphosphonate 27 41 3372 3386 B-treatment
or 42 44 3387 3389 O
denosumab 45 54 3390 3399 B-treatment
therapy 55 62 3400 3407 I-treatment

Patients 0 8 3408 3416 O
receiving 9 18 3417 3426 O
other 19 24 3427 3432 O
treatment 25 34 3433 3442 B-treatment
for 35 38 3443 3446 O
breast 39 45 3447 3453 B-cancer
cancer 46 52 3454 3460 I-cancer
( 53 54 3461 3462 O
includes 54 62 3462 3470 O
standard 63 71 3471 3479 B-treatment
hormonal 72 80 3480 3488 I-treatment
therapy 81 88 3489 3496 I-treatment
, 88 89 3496 3497 O
chemotherapy 90 102 3498 3510 B-treatment
, 102 103 3510 3511 O
biologic 104 112 3512 3520 B-treatment
therapy 113 120 3521 3528 I-treatment
, 120 121 3528 3529 O
immunotherapy 122 135 3530 3543 B-treatment
, 135 136 3543 3544 O
or 137 139 3545 3547 O
radiation 140 149 3548 3557 B-treatment
therapy 150 157 3558 3565 I-treatment
) 157 158 3565 3566 O

Patients 0 8 3567 3575 O
with 9 13 3576 3580 O
breast 14 20 3581 3587 B-cancer
tumors 21 27 3588 3594 I-cancer
that 28 32 3595 3599 O
are 33 36 3600 3603 O
AR+ 37 40 3604 3607 B-clinical_variable
( 41 42 3608 3609 O
≥10 42 45 3609 3612 O
% 45 46 3612 3613 I-lower_bound
staining 47 55 3614 3622 I-lower_bound
by 56 58 3623 3625 O
immunohisto 59 70 3626 3637 B-treatment
- 70 71 3637 3638 I-treatment
chemistry 71 80 3638 3647 I-treatment
) 80 81 3647 3648 O

Patients 0 8 3649 3657 O
with 9 13 3658 3662 O
known 14 19 3663 3668 O
adrenal 20 27 3669 3676 B-chronic_disease
insufficiency 28 41 3677 3690 I-chronic_disease
, 41 42 3690 3691 O
or 43 45 3692 3694 O
patients 46 54 3695 3703 O
receiving 55 64 3704 3713 O
treatment 65 74 3714 3723 B-treatment
with 75 79 3724 3728 I-treatment
ketoconazole 80 92 3729 3741 I-treatment
, 92 93 3741 3742 O
abiraterone 94 105 3743 3754 B-treatment
, 105 106 3754 3755 O
or 107 109 3756 3758 O
aminoglutethimide 110 127 3759 3776 B-treatment

Patients 0 8 3777 3785 O
with 9 13 3786 3790 O
metastases 14 24 3791 3801 B-cancer
limited 25 32 3802 3809 I-cancer
to 33 35 3810 3812 I-cancer
the 36 39 3813 3816 I-cancer
bones 40 45 3817 3822 I-cancer

Platelets 0 9 3823 3832 B-clinical_variable
≥75 10 13 3833 3836 O
x 14 15 3837 3838 I-lower_bound
109 16 19 3839 3842 I-lower_bound
/ 19 20 3842 3843 I-lower_bound
L 20 21 3843 3844 I-lower_bound

Presence 0 8 3845 3853 O
of 9 11 3854 3856 O
active 12 18 3857 3863 O
gastrointestinal 19 35 3864 3880 B-chronic_disease
( 36 37 3881 3882 I-chronic_disease
GI 37 39 3882 3884 I-chronic_disease
) 39 40 3884 3885 I-chronic_disease
disease 41 48 3886 3893 I-chronic_disease
or 49 51 3894 3896 O
other 52 57 3897 3902 O
condition 58 67 3903 3912 O
that 68 72 3913 3917 O
will 73 77 3918 3922 O
interfere 78 87 3923 3932 O
significantly 88 101 3933 3946 O
with 102 106 3947 3951 O
the 107 110 3952 3955 O
absorption 111 121 3956 3966 O
, 121 122 3966 3967 O
distribution 123 135 3968 3980 O
, 135 136 3980 3981 O
metabolism 137 147 3982 3992 O
, 147 148 3992 3993 O
or 149 151 3994 3996 O
excretion 152 161 3997 4006 O
of 162 164 4007 4009 O
oral 165 169 4010 4014 B-treatment
therapy 170 177 4015 4022 I-treatment
( 178 179 4023 4024 O
eg 179 181 4024 4026 O
, 181 182 4026 4027 O
ulcerative 183 193 4028 4038 B-chronic_disease
disease 194 201 4039 4046 I-chronic_disease
, 201 202 4046 4047 O
uncontrolled 203 215 4048 4060 O
nausea 216 222 4061 4067 O
, 222 223 4067 4068 O
vomiting 224 232 4069 4077 O
, 232 233 4077 4078 O
diarrhea 234 242 4079 4087 B-clinical_variable
≥ 243 244 4088 4089 O
Grade 245 250 4090 4095 B-lower_bound
2 251 252 4096 4097 I-lower_bound
, 252 253 4097 4098 O
and 254 257 4099 4102 O
malabsorption 258 271 4103 4116 B-chronic_disease
syndrome 272 280 4117 4125 I-chronic_disease
) 280 281 4125 4126 O

Previously 0 10 4127 4137 O
treated 11 18 4138 4145 O
brain 19 24 4146 4151 B-cancer
metastases 25 35 4152 4162 I-cancer
are 36 39 4163 4166 O
allowed 40 47 4167 4174 O
provided 48 56 4175 4183 O
lesions 57 64 4184 4191 B-cancer
are 65 68 4192 4195 O
stable 69 75 4196 4202 O
for 76 79 4203 4206 O
at 80 82 4207 4209 O
least 83 88 4210 4215 O
3 89 90 4216 4217 B-lower_bound
months 91 97 4218 4224 I-lower_bound
as 98 100 4225 4227 O
documented 101 111 4228 4238 O
by 112 114 4239 4241 O
head 115 119 4242 4246 B-treatment
CT 120 122 4247 4249 I-treatment
scan 123 127 4250 4254 I-treatment
or 128 130 4255 4257 O
magnetic 131 139 4258 4266 B-treatment
resonance 140 149 4267 4276 I-treatment
imaging 150 157 4277 4284 I-treatment
( 158 159 4285 4286 I-treatment
MRI 159 162 4286 4289 I-treatment
) 162 163 4289 4290 I-treatment
of 164 166 4291 4293 I-treatment
the 167 170 4294 4297 I-treatment
brain 171 176 4298 4303 I-treatment

Prior 0 5 4304 4309 B-treatment
anti 6 10 4310 4314 I-treatment
- 10 11 4314 4315 I-treatment
androgen 11 19 4315 4323 I-treatment
therapy 20 27 4324 4331 I-treatment

Screening 0 9 4332 4341 O
calculated 10 20 4342 4352 O
LVEF 21 25 4353 4357 B-clinical_variable
of 26 28 4358 4360 O
≥50 29 32 4361 4364 O
% 32 33 4364 4365 I-lower_bound
by 34 36 4366 4368 O
echocardiogram 37 51 4369 4383 B-treatment
( 52 53 4384 4385 I-treatment
ECHO 53 57 4385 4389 I-treatment
) 57 58 4389 4390 I-treatment
or 59 61 4391 4393 O
multiple 62 70 4394 4402 B-treatment
- 70 71 4402 4403 I-treatment
gated 71 76 4403 4408 I-treatment
acquisition 77 88 4409 4420 I-treatment
( 89 90 4421 4422 I-treatment
MUGA 90 94 4422 4426 I-treatment
) 94 95 4426 4427 I-treatment
scan 96 100 4428 4432 I-treatment

This 0 4 4433 4437 O
group 5 10 4438 4443 O
of 11 13 4444 4446 O
patients 14 22 4447 4455 O
may 23 26 4456 4459 O
be 27 29 4460 4462 O
pre 30 33 4463 4466 O
- 33 34 4466 4467 O
menopausal 34 44 4467 4477 O
with 45 49 4478 4482 O
ovarian 50 57 4483 4490 B-treatment
suppression 58 69 4491 4502 I-treatment
or 70 72 4503 4505 O
post 73 77 4506 4510 O
- 77 78 4510 4511 O
menopausal 78 88 4511 4521 O

This 0 4 4522 4526 O
group 5 10 4527 4532 O
of 11 13 4533 4535 O
patients 14 22 4536 4544 O
must 23 27 4545 4549 O
have 28 32 4550 4554 O
received 33 41 4555 4563 O
at 42 44 4564 4566 O
least 45 50 4567 4572 O
1 51 52 4573 4574 B-lower_bound
and 53 56 4575 4578 O
up 57 59 4579 4581 O
to 60 62 4582 4584 O
3 63 64 4585 4586 B-upper_bound
prior 65 70 4587 4592 B-treatment
chemotherapy 71 83 4593 4605 I-treatment
regimens 84 92 4606 4614 I-treatment
in 93 95 4615 4617 I-treatment
the 96 99 4618 4621 I-treatment
advanced 100 108 4622 4630 I-treatment
setting 109 116 4631 4638 I-treatment

This 0 4 4639 4643 O
group 5 10 4644 4649 O
of 11 13 4650 4652 O
patients 14 22 4653 4661 O
must 23 27 4662 4666 O
have 28 32 4667 4671 O
received 33 41 4672 4680 O
at 42 44 4681 4683 O
least 45 50 4684 4689 O
1 51 52 4690 4691 B-lower_bound
and 53 56 4692 4695 O
up 57 59 4696 4698 O
to 60 62 4699 4701 O
3 63 64 4702 4703 B-upper_bound
prior 65 70 4704 4709 B-treatment
hormonal 71 79 4710 4718 I-treatment
therapies 80 89 4719 4728 I-treatment
and 90 93 4729 4732 O
at 94 96 4733 4735 O
least 97 102 4736 4741 O
one 103 106 4742 4745 B-lower_bound
prior 107 112 4746 4751 B-treatment
chemotherapy 113 125 4752 4764 I-treatment
treatment 126 135 4765 4774 I-treatment
in 136 138 4775 4777 I-treatment
the 139 142 4778 4781 I-treatment
advanced 143 151 4782 4790 I-treatment
setting 152 159 4791 4798 I-treatment

Total 0 5 4799 4804 O
bilirubin 6 15 4805 4814 B-clinical_variable
≤1.5 16 20 4815 4819 O
times 21 26 4820 4825 I-upper_bound
the 27 30 4826 4829 I-upper_bound
upper 31 36 4830 4835 I-upper_bound
limit 37 42 4836 4841 I-upper_bound
of 43 45 4842 4844 I-upper_bound
normal 46 52 4845 4851 I-upper_bound
( 53 54 4852 4853 I-upper_bound
ULN 54 57 4853 4856 I-upper_bound
) 57 58 4856 4857 I-upper_bound

Triple 0 6 4858 4864 B-cancer
negative 7 15 4865 4873 I-cancer
( 16 17 4874 4875 O
ER-/PR-/HER2- 17 30 4875 4888 B-clinical_variable
) 30 31 4888 4889 O

Uncontrolled 0 12 4890 4902 O
diabetes 13 21 4903 4911 B-chronic_disease
mellitus 22 30 4912 4920 I-chronic_disease

Use 0 3 4921 4924 O
of 4 6 4925 4927 O
a 7 8 4928 4929 O
prohibited 9 19 4930 4940 O
concomitant 20 31 4941 4952 B-treatment
medication 32 42 4953 4963 I-treatment
that 43 47 4964 4968 O
can 48 51 4969 4972 O
not 51 54 4972 4975 O
be 55 57 4976 4978 O
safely 58 64 4979 4985 O
discontinued 65 77 4986 4998 O
or 78 80 4999 5001 O
substituted 81 92 5002 5013 O

Use 0 3 5014 5017 O
of 4 6 5018 5020 O
an 7 9 5021 5023 O
investigational 10 25 5024 5039 B-treatment
drug 26 30 5040 5044 I-treatment
≤21 31 34 5045 5048 O
days 35 39 5049 5053 I-upper_bound
or 40 42 5054 5056 O
5 43 44 5057 5058 B-upper_bound
half 45 49 5059 5063 I-upper_bound
- 49 50 5063 5064 I-upper_bound
lives 50 55 5064 5069 I-upper_bound
( 56 57 5070 5071 O
whichever 57 66 5071 5080 O
is 67 69 5081 5083 O
shorter 70 77 5084 5091 O
) 77 78 5091 5092 O
prior 79 84 5093 5098 O
to 85 87 5099 5101 O
the 88 91 5102 5105 O
first 92 97 5106 5111 O
dose 98 102 5112 5116 O
of 103 105 5117 5119 O
orteronel 106 115 5120 5129 B-treatment
, 115 116 5129 5130 O
or 117 119 5131 5133 O
concurrent 120 130 5134 5144 O
treatment 131 140 5145 5154 B-treatment

Wide 0 4 5155 5159 B-treatment
field 5 10 5160 5165 I-treatment
radiotherapy 11 23 5166 5178 I-treatment
( 24 25 5179 5180 O
including 25 34 5180 5189 O
therapeutic 35 46 5190 5201 B-treatment
radioisotopes 47 60 5202 5215 I-treatment
such 61 65 5216 5220 O
as 66 68 5221 5223 O
strontium 69 78 5224 5233 B-treatment
89 79 81 5234 5236 I-treatment
) 81 82 5236 5237 O
administered 83 95 5238 5250 O
≤28 96 99 5251 5254 O
days 100 104 5255 5259 I-upper_bound
or 105 107 5260 5262 O
limited 108 115 5263 5270 B-treatment
field 116 121 5271 5276 I-treatment
radiation 122 131 5277 5286 I-treatment
for 132 135 5287 5290 O
palliation 136 146 5291 5301 O
≤7 147 149 5302 5304 O
days 150 154 5305 5309 I-upper_bound
prior 155 160 5310 5315 I-upper_bound
to 161 163 5316 5318 O
starting 164 172 5319 5327 O
study 173 178 5328 5333 O
drug 179 183 5334 5338 O
or 184 186 5339 5341 O
has 187 190 5342 5345 O
not 191 194 5346 5349 O
recovered 195 204 5350 5359 O
from 205 209 5360 5364 O
side 210 214 5365 5369 O
effects 215 222 5370 5377 O
of 223 225 5378 5380 O
such 226 230 5381 5385 O
therapy 231 238 5386 5393 O

alopecia 0 8 5394 5402 B-chronic_disease

in 0 2 5403 5405 O
patients 3 11 5406 5414 O
with 12 16 5415 5419 O
known 17 22 5420 5425 O
Gilbert 23 30 5426 5433 B-chronic_disease
Syndrome 31 39 5434 5442 I-chronic_disease
, 39 40 5442 5443 O
a 41 42 5444 5445 O
total 43 48 5446 5451 B-clinical_variable
bilirubin 49 58 5452 5461 I-clinical_variable
≤3.0 59 63 5462 5466 O
x 64 65 5467 5468 I-upper_bound
ULN 66 69 5469 5472 I-upper_bound
, 69 70 5472 5473 O
with 71 75 5474 5478 O
direct 76 82 5479 5485 B-clinical_variable
bilirubin 83 92 5486 5495 I-clinical_variable
≤1.5 93 97 5496 5500 O
x 98 99 5501 5502 I-upper_bound
ULN 100 103 5503 5506 I-upper_bound

male 0 4 5507 5511 B-gender

patients 0 8 5512 5520 O
≥18 9 12 5521 5524 O
years 13 18 5525 5530 I-lower_bound
- 18 19 5530 5531 O
of 19 21 5531 5533 O
- 21 22 5533 5534 O
age 22 25 5534 5537 B-age

